Drug Screening Market COVID – 19 | Updated Analysis By Top Key Players – Alere, Thermo Fisher & Shimadzu

Factors such as growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and regulatory approvals and new product & service launches are driving the growth of the market.

Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) – Global Forecast to 2022

The drug screening market was valued at USD 4.86 Billion in 2016 and is expected to reach USD 8.63 Billion by 2022, growing at a CAGR of 10.2% during the forecast period.

The global Drug Screening Market is Segmented on:
1. Product
2. Drug Screening Services
3. Sample Type
4. End User

 

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773

The objectives of this study are as follows:

• To define, describe, segment, and forecast the global market by product and service, sample type, end user, and region To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, challenges, and market-specific trends)
•  To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of competitive landscape for market leaders
• To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). To profile key players and comprehensively analyze their market shares and core competencies
• To track and analyze competitive developments such as agreements, partnerships, and collaborations; acquisitions; product launches and approvals; expansions; and R&D activities in the global market.

Breathalyzers are expected to dominate the drug screening products market in 2017.
Based on product, the drug screening market is segmented into analytical instruments, rapid testing devices, and consumables. In 2017, the breathalyzers segment is expected to dominate the market. Growing alcohol consumption and drunken driving cases, stringent government laws mandating drug and alcohol testing, and technological advancements in this market are some of the key factors driving the growth of the breathalyzers market.

Target Audience for this Report:

• Drug and alcohol testing laboratories
• Drug and alcohol testing product manufacturing companies
• Rapid drug screening device manufacturers
• Law enforcement agencies
• Healthcare providers
• Government agencies
• Research and consulting firms
• Venture capitalists

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773

Regional Analysis:
In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as growing consumption of illicit drugs, the availability of government funding to curb drug addiction, presence of laws supporting drug screening, and growing burden of road accidents due to alcohol consumption in the region.